139 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Lupus Erythematosus, Systemic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Systemic Lupus Erythematous and Heart Conduction Disorders
Conditions: Lupus Erythematosus, Systemic;   Atrioventricular Block;   Sudden Death
Intervention: Other: No intervention
2 Unknown  Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid
Intervention:
3 Unknown  Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
4 Unknown  Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
5 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
6 Recruiting Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atacicept 75 milligram (mg);   Drug: Atacicept 150 mg;   Drug: Placebo
7 Not yet recruiting Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Patients Who Participated in ADDRESS II)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atacicept 75 mg;   Drug: Atacicept 150 mg
8 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
9 Recruiting Study of Systemic Lupus Erythematosus
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention:
10 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
11 Recruiting CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: blisibimod;   Drug: Placebo
12 Recruiting Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)
Condition: Systemic Lupus
Intervention: Drug: Arsenic trioxide
13 Not yet recruiting CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
14 Unknown  Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Condition: Refractory Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic MSC (AlloMSC)
15 Unknown  Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Other: Preventive Cardiology;   Other: Usual Care
16 Recruiting Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.
Conditions: Systemic Lupus Erythematosus;   Sleep Disorders
Interventions: Procedure: Aerobic Exercise;   Other: Control Group
17 Recruiting GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Genetic: Blood sampling
18 Recruiting International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
19 Recruiting Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Conditions: Systemic Lupus Erythematosus;   Antiphospholipid Syndrome
Intervention:
20 Unknown  Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years